Related Experiment Video
Updated: Jul 20, 2026

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
Polycystic ovarian syndrome: the next cardiovascular dilemma in women?
Preethi Srikanthan1, Stanley Korenman, Susan Davis
1Department of Epidemiology and Preventative Medicine, University of California Los Angeles, Box 957065, 330 South Garfield Avenue, Suite 308, Los Angeles, CA 90095, USA.
Insights
Women with polycystic ovary syndrome (PCOS) face higher cardiovascular disease risks. Addressing the cluster of risk factors in PCOS is key for prevention and therapy.
Area of Science:
- Endocrinology
- Cardiovascular Medicine
- Reproductive Health
Background:
- Polycystic ovary syndrome (PCOS) is associated with increased risks for cardiovascular disease (CVD).
- PCOS presents with symptoms like amenorrhea, hirsutism, and obesity.
- Familial studies indicate a predisposition to PCOS, diabetes, hypertension, and CVD.
Purpose of the Study:
- To highlight the multifaceted cardiovascular risks in women with PCOS.
- To discuss the diagnostic and research challenges posed by PCOS heterogeneity.
- To propose a focus on the combined cardiovascular risk milieu for preventative strategies.
Main Methods:
- Review of epidemiologic studies and clinical observations in PCOS patients.
- Analysis of the co-existence of cardiovascular risk factors within the PCOS population.
- Discussion of the role of insulin resistance and other contributing factors.
Main Results:
- All known cardiovascular disease risks are elevated in women with PCOS.
- A familial link exists between PCOS and conditions such as diabetes, hypertension, and CVD.
- Phenotypic heterogeneity complicates diagnosis and research.
Conclusions:
- Insulin resistance is a significant factor in some PCOS cases.
- The concurrent presence of multiple CVD risk factors in PCOS patients creates a critical milieu.
- Targeting this overall risk milieu is a promising strategy for prevention and therapy in PCOS.
Abstract:
All known risks for cardiovascular disease are increased in women with polycystic ovary syndrome, which features amenorrhea, hirsutism, and obesity. Epidemiologic studies in these patients and their families have revealed a familial predisposition not only to polycystic ovary syndrome, but also diabetes, hypertension, and cardiovascular disease. The heterogeneity of phenotypes (clinically and biochemically) leads to difficulty in achieving a precise diagnosis, defining a single underlying pathogenesis, and selecting a homogeneous population for much needed prospective studies. The authors believe that while insulin resistance plays and important role in some cases of polycystic ovarian syndrome, it is the overall milieu created by the co-existence of several cardiovascular risk factors in polycystic ovarian syndrome patients which could be an important target for preventative strategies and therapy.
Related Concept Videos
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Type II Diabetes I: Introduction
Oogenesis
Disorders of the Female Reproductive System
Coronary Artery Disease II: Pathophysiology

